Junpei Rikitake

发表

Effect of tumor burden and growth rate on treatment outcomes of nivolumab in head and neck cancer

K. Nibu, N. Kiyota, N. Otsuki, 2020, International Journal of Clinical Oncology.

Case Report: Composite Angioimmunoblastic T-Cell Lymphoma and Epstein-Barr Virus-Positive B-Cell Lymphoproliferative Disorder as Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders

Y. Hayashi, K. Yakushijin, K. Kajimoto, 2020, Frontiers in Medicine.

Autoimmune Myelofibrosis in Sjögren’s Syndrome: Report of a Case

Y. Hayashi, K. Kajimoto, Seiji Kakiuchi, 2020, The American journal of case reports.

Discontinuation of sorafenib can lead to the emergence of FLT3-ITD-positive acute myeloid leukemia

H. Matsuoka, H. Minami, N. Kiyota, 2018, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.